Jan Haesaert

Senior Sales Agent at iVascular

Jan Haesaert has a strong background in sales and product specialization within the medical field, with extensive experience since 1988. Currently, Jan serves as a Senior Sales Agent at iVascular, focusing on sales in the hospitals of Flanders and Wallonia, targeting vascular surgeons, interventional radiologists, and interventional cardiologists. Previously, Jan worked at Johnson & Johnson as a product specialist for endovascular products, managing a portfolio for surgeons and interventional radiologists. Early career roles included sales positions in pneumology at GlaxoSmithKline and diagnostics at Syva-Biomerieux, as well as an educational role teaching science in Zambia. Jan holds a Master's degree in Biotechnology from Rijksuniversiteit Gent, obtained between 1982 and 1987.

Location

Ghent, Belgium

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


iVascular

1 followers

The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global